Neovasc Inc. Retained Earnings

Retained Earnings of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Retained Earnings growth rates and interactive chart.


Highlights and Quick Summary

  • Retained Earnings for the quarter ending March 31, 2022 was $-432 Million (a 3.42% increase compared to previous quarter)
  • Year-over-year quarterly Retained Earnings increased by 6.47%
  • Annual Retained Earnings for 2021 was $-418 Million (a 5.39% increase from previous year)
  • Annual Retained Earnings for 2020 was $-396 Million (a 8.44% increase from previous year)
  • Annual Retained Earnings for 2019 was $-366 Million (a 9.86% increase from previous year)
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Retained Earnings of Neovasc Inc.

Most recent Retained Earningsof NVCN including historical data for past 10 years.

Interactive Chart of Retained Earnings of Neovasc Inc.

Neovasc Inc. Retained Earnings for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-432.15
2021 $-417.85 $-412.94 $-405.87 $-396.4 $-417.85
2020 $-396.47 $-390.8 $-380.57 $-370.64 $-396.47
2019 $-366.53 $-355.51 $-349.31 $-341.35 $-365.62
2018 $-331.4 $-342.98 $-329.72 $-280.57 $-332.81
2017 $-224.69 $-219.67 $-214.97 $-209.63 $-225.22
2016 $-201.78 $-209.86 $-126.17 $-201.78
2015 $-115.29 $-93.1 $-90.78 $-83.48 $-115.29
2014 $-88.55 $-82.31 $-77.88 $-71.23 $-88.56
2013 $-75.86 $-73.03 $-72.77 $-72.66 $-75.86
2012 $-71.38 $-75.31 $-73.08 $-72.12 $-71.38
2011 $-70.99 $-70.99

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.